Dr. William E. Timberlake Ph.D.

Bill Timberlake Vice President ~ 913-814-0276*

Dr. Bill Timberlake, Monsanto Corporation
...
Dr. Bill Timberlake, Chief Technical Officer, Monsanto CorporationGenetically modified crops pioneered by Monsanto have gained wide acceptance and large market shares because of the value they provide to farmers and ultimately to consumers.The first traits to be commercialized in transgenic crops, herbicide and insect tolerance, utilized genes isolated from microorganisms.Due to the metabolic diversity of microorganisms and the large number of species it is likely they will continue to be the primary source of transgenes.Monsanto has therefore developed both plant and microbial structural and functional genomics programs to provide the genes for its future products.

ChemGenics' scientists and advisors include worldwide leaders in microbial molecular biology and genetics, including scientific advisory board members, Gerald R. Fink, Ph.D., Director of the Whitehead Institute for Biomedical Research, and Richard Losick, Ph.D., Chairman, Department of Molecular and Cellular Biology at Harvard; and William Timberlake, Ph.D., ChemGenics' Executive Vice President for Research.

ChemGenics' scientists and advisors include worldwide leaders in microbial molecular biology and genetics , including scientific advisory board members , Gerald R. Fink , Ph.D. , Director of the Whitehead Institute for Biomedical Research , and Richard Losick , Ph.D. , Chairman , Department of Molecular and Cellular Biology at Harvard ; and William Timberlake , Ph.D. , ChemGenics' Executive Vice President for Research.

William E. Timberlake And David A. Fischhoff Lead CereonMonsanto - Media - Monsanto Statements & News Releases 1998 - 02/24/98 Monsanto/ Millennium alliance named Cereon Genomics L.I. - Developing Sustainable Agriculture, Agricultural Solutions, Crop Biotechnology and Genetically Modified Food

...
William E. Timberlake And David A. Fischhoff Lead Cereon

CAMBRIDGE, Mass., February 24, 1998 - William E. Timberlake and David A. Fischhoff will lead Cereon Genomics L.L.C., the genomics alliance between Monsanto Company and Millennium Pharmaceuticals Inc. created to apply genomics technologies to the discovery and development of plant and agricultural products.
...
Timberlake, 49, currently chief discovery officer for Millennium, and Fischhoff, 45, currently director, advanced genomics, and global business director for Monsanto's corn business, will share responsibility for leading Cereon as co-presidents.
...
Timberlake joined Millennium Pharmaceuticals in 1997 through the merger of Millennium and ChemGenics Pharmaceuticals Inc.At ChemGenics (formerly Myco Pharmaceuticals Inc.), he was a founding member of the scientific advisory board and executive vice president of research.Prior to joining Myco in 1993, Timberlake taught graduate and undergraduate courses including genetics and recombinant DNA technology for 20 years at Wayne State University, the University of California at Davis, and the University of Georgia.

He is the author or co-author of more than 100 scientific papers and holds two U.S. patents.Timberlake earned a doctorate in biochemistry from Syracuse University in 1973.He also did post-doctoral studies in molecular biology and genetics at the University of Geneva.

...
As co-presidents of Cereon, Timberlake and Fischhoff will be responsible for creating an enterprise dedicated to using leading-edge genomics technologies to help discover and develop a wide range of plant and agricultural products.
...
"This is an exciting time to be working in the field of genomics," Timberlake said."As we learn more about plant, animal and human genomes, we'll be able to apply that knowledge to a wide range of problems.Our hope is for Cereon scientists to be among the leaders in how genes function and interact, and applying their findings to create environmentally friendly crops and healthier-for-you foods."

Cereon is currently hiring specialists in the fields of molecular genetics, bioinformatics, high throughput sequencing, gene expression and plant biology.While some employees from Millennium and Monsanto are expected to join Cereon, the majority of employees will come from outside the two collaborating companies.By the end of 1998, Cereon is expected to employ up to 100 people.

William E. Timberlake And David A. Fischhoff Lead CereonMonsanto - Media - Monsanto Statements & News Releases 1998 - 02/24/98 Monsanto/ Millennium alliance named Cereon Genomics L.I. - Developing Sustainable Agriculture, Agricultural Solutions, Crop Biotechnology and Genetically Modified Food
...
William E. Timberlake And David A. Fischhoff Lead Cereon

CAMBRIDGE, Mass., February 24, 1998 - William E. Timberlake and David A. Fischhoff will lead Cereon Genomics L.L.C., the genomics alliance between Monsanto Company and Millennium Pharmaceuticals Inc. created to apply genomics technologies to the discovery and development of plant and agricultural products.
...
Timberlake, 49, currently chief discovery officer for Millennium, and Fischhoff, 45, currently director, advanced genomics, and global business director for Monsanto's corn business, will share responsibility for leading Cereon as co-presidents.
...
Timberlake joined Millennium Pharmaceuticals in 1997 through the merger of Millennium and ChemGenics Pharmaceuticals Inc.At ChemGenics (formerly Myco Pharmaceuticals Inc.), he was a founding member of the scientific advisory board and executive vice president of research.Prior to joining Myco in 1993, Timberlake taught graduate and undergraduate courses including genetics and recombinant DNA technology for 20 years at Wayne State University, the University of California at Davis, and the University of Georgia.

He is the author or co-author of more than 100 scientific papers and holds two U.S. patents.Timberlake earned a doctorate in biochemistry from Syracuse University in 1973.He also did post-doctoral studies in molecular biology and genetics at the University of Geneva.

...
As co-presidents of Cereon, Timberlake and Fischhoff will be responsible for creating an enterprise dedicated to using leading-edge genomics technologies to help discover and develop a wide range of plant and agricultural products.
...
"This is an exciting time to be working in the field of genomics," Timberlake said."As we learn more about plant, animal and human genomes, we'll be able to apply that knowledge to a wide range of problems.Our hope is for Cereon scientists to be among the leaders in how genes function and interact, and applying their findings to create environmentally friendly crops and healthier-for-you foods."

Cereon is currently hiring specialists in the fields of molecular genetics, bioinformatics, high throughput sequencing, gene expression and plant biology.While some employees from Millennium and Monsanto are expected to join Cereon, the majority of employees will come from outside the two collaborating companies.By the end of 1998, Cereon is expected to employ up to 100 people.

David M. Geiser, Michael L. Arnold, and William E. Timberlake, University of Georgia, Athens, GA